Latest Insider Transactions at Star Equity Holdings, Inc. (STRR)
This section provides a real-time view of insider transactions for Star Equity Holdings, Inc. (STRR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of STAR EQUITY HOLDINGS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of STAR EQUITY HOLDINGS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 27
2022
|
Jeffrey E. Eberwein Executive Chairman |
BUY
Open market or private purchase
|
Direct |
8,354
+0.4%
|
$0
$0.94 P/Share
|
|
May 26
2022
|
Jeffrey E. Eberwein Executive Chairman |
BUY
Open market or private purchase
|
Direct |
38,341
+1.82%
|
$0
$0.91 P/Share
|
|
May 25
2022
|
Jeffrey E. Eberwein Executive Chairman |
BUY
Open market or private purchase
|
Direct |
68,665
+3.26%
|
$0
$0.82 P/Share
|
|
May 15
2022
|
Michael A. Cunnion Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,950
+11.5%
|
-
|
|
May 15
2022
|
Jeffrey E. Eberwein Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
8,398
+0.43%
|
-
|
|
May 15
2022
|
Mitchell I Quain Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,881
+15.75%
|
-
|
|
May 15
2022
|
John W. Sayward Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,950
+12.29%
|
-
|
|
Mar 31
2022
|
Michael A. Cunnion Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,885
+5.83%
|
-
|
|
Mar 31
2022
|
Jeffrey E. Eberwein Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
34,937
+0.88%
|
-
|
|
Mar 31
2022
|
Mitchell I Quain Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,885
+6.95%
|
-
|
|
Mar 31
2022
|
John W. Sayward Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,885
+6.33%
|
-
|
|
Mar 03
2022
|
Jeffrey E. Eberwein Executive Chairman |
SELL
Open market or private sale
|
Direct |
206
-0.02%
|
$2,060
$10.49 P/Share
|
|
Mar 03
2022
|
David J. Noble Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,230
-1.32%
|
$1,230
$1.24 P/Share
|
|
Mar 03
2022
|
David J. Noble Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,311
+3.44%
|
-
|
|
Feb 28
2022
|
Matthew G. Molchan Pres. & CEO Digirad Health |
SELL
Payment of exercise price or tax liability
|
Direct |
470
-1.32%
|
$470
$1.21 P/Share
|
|
Feb 28
2022
|
Matthew G. Molchan Pres. & CEO Digirad Health |
BUY
Exercise of conversion of derivative security
|
Direct |
1,327
+3.6%
|
-
|
|
Feb 28
2022
|
Martin B Shirley President - DIS |
SELL
Payment of exercise price or tax liability
|
Direct |
104
-0.99%
|
$104
$1.21 P/Share
|
|
Feb 28
2022
|
Martin B Shirley President - DIS |
BUY
Exercise of conversion of derivative security
|
Direct |
350
+3.23%
|
-
|
|
Jan 24
2022
|
Richard Kenneth Coleman Jr. Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
33,400
+50.0%
|
$33,400
$1.49 P/Share
|
|
Jan 24
2022
|
Michael A. Cunnion Director |
BUY
Open market or private purchase
|
Direct |
8,300
+15.97%
|
$8,300
$1.49 P/Share
|
|
Jan 24
2022
|
Jeffrey E. Eberwein Executive Chairman |
BUY
Open market or private purchase
|
Direct |
1,075,000
+35.85%
|
$1,075,000
$1.49 P/Share
|
|
Jan 24
2022
|
John W Gildea Director |
BUY
Open market or private purchase
|
Direct |
33,400
+42.88%
|
$33,400
$1.49 P/Share
|
|
Jan 24
2022
|
David J. Noble Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
30,000
+25.08%
|
$30,000
$1.49 P/Share
|
|
Dec 10
2021
|
Jeffrey E. Eberwein Executive Chairman |
BUY
Open market or private purchase
|
Direct |
650,000
+43.38%
|
$1,950,000
$3.25 P/Share
|
|
Nov 24
2021
|
Jeffrey E. Eberwein Executive Chairman |
SELL
Open market or private sale
|
Direct |
1,074
-0.08%
|
$10,740
$10.57 P/Share
|
|
Nov 23
2021
|
Jeffrey E. Eberwein Executive Chairman |
SELL
Open market or private sale
|
Direct |
12,010
-0.92%
|
$120,100
$10.52 P/Share
|
|
Nov 22
2021
|
Jeffrey E. Eberwein Executive Chairman |
SELL
Open market or private sale
|
Direct |
5,916
-0.45%
|
$59,160
$10.51 P/Share
|
|
Nov 19
2021
|
John W. Sayward Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,719
+8.55%
|
-
|
|
Nov 19
2021
|
Mitchell I Quain Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,719
+9.42%
|
-
|
|
Nov 19
2021
|
Jeffrey E. Eberwein Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
3,719
+1.84%
|
-
|
|
Nov 19
2021
|
Michael A. Cunnion Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,719
+9.51%
|
-
|
|
Aug 20
2021
|
Jeffrey E. Eberwein Executive Chairman |
SELL
Open market or private sale
|
Direct |
1,058
-0.16%
|
$10,580
$10.49 P/Share
|
|
Aug 17
2021
|
Michael A. Cunnion Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,358
+9.59%
|
-
|
|
Aug 17
2021
|
Jeffrey E. Eberwein Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
3,358
+1.7%
|
-
|
|
Aug 17
2021
|
Mitchell I Quain Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,358
+9.49%
|
-
|
|
Aug 17
2021
|
John W. Sayward Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,358
+8.52%
|
-
|
|
Aug 07
2021
|
Jeffrey E. Eberwein Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+5.91%
|
-
|
|
Aug 07
2021
|
John W. Sayward Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+26.85%
|
-
|
|
Aug 07
2021
|
Mitchell I Quain Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+29.5%
|
-
|
|
Aug 07
2021
|
Michael A. Cunnion Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+29.78%
|
-
|
|
Jun 15
2021
|
Mitchell I Quain Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
11,000
+21.98%
|
$22,000
$2.25 P/Share
|
|
Jun 07
2021
|
Jeffrey E. Eberwein Executive Chairman |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
22,000
+10.93%
|
$44,000
$2.25 P/Share
|
|
May 15
2021
|
Matthew G. Molchan Pres. & CEO Digirad Health |
SELL
Payment of exercise price or tax liability
|
Direct |
2,144
-5.89%
|
$4,288
$2.59 P/Share
|
|
May 15
2021
|
Matthew G. Molchan Pres. & CEO Digirad Health |
BUY
Exercise of conversion of derivative security
|
Direct |
7,120
+16.36%
|
-
|
|
May 15
2021
|
David J. Noble Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,146
+13.3%
|
-
|
|
May 15
2021
|
Martin B Shirley President - DIS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,046
-9.37%
|
$2,092
$2.59 P/Share
|
|
May 15
2021
|
Martin B Shirley President - DIS |
BUY
Exercise of conversion of derivative security
|
Direct |
4,459
+28.53%
|
-
|
|
Feb 28
2021
|
Matthew G. Molchan Pres. & CEO Digirad Health |
SELL
Payment of exercise price or tax liability
|
Direct |
842
-1.44%
|
$2,526
$3.38 P/Share
|
|
Feb 28
2021
|
Matthew G. Molchan Pres. & CEO Digirad Health |
BUY
Exercise of conversion of derivative security
|
Direct |
2,376
+3.89%
|
-
|
|
Feb 28
2021
|
Martin B Shirley President - DIS |
SELL
Payment of exercise price or tax liability
|
Direct |
186
-1.39%
|
$558
$3.38 P/Share
|